2010
DOI: 10.1590/s0365-05962010000500017
|View full text |Cite
|
Sign up to set email alerts
|

Ocronose exógena induzida por hidroquinona: relato de quatro casos

Abstract: Exogenous ochronosis is an infrequent dermatosis characterized as a dark blue hyperpigmentation localized where the causing agent was applied. It may be caused by the use of systemic medication such as antimalarials and by the use of topic substances such as phenol, resorcinol, benzene, or hydroquinone, which is a fenolic compound with depigmentation action, largely used in the treatment of melasma and other hyperpigmentation. The physiopathology of this process is not well clear up to this moment, and the the… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
5
0

Year Published

2011
2011
2023
2023

Publication Types

Select...
5
2

Relationship

0
7

Authors

Journals

citations
Cited by 23 publications
(5 citation statements)
references
References 4 publications
0
5
0
Order By: Relevance
“…Some reports describe cases of EO with use of concentrations of hydroquinone 2%, suggesting that in some patients the concentration of the substance is not the most important risk factor. 10,11 The high prevalence of pigmentary disorders in patients with high phtotype in Fitzpatrick scale would be one of the factors for a greater number of described cases in this population. However, there are reports in patients who are Asian and Caucasian descendants.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…Some reports describe cases of EO with use of concentrations of hydroquinone 2%, suggesting that in some patients the concentration of the substance is not the most important risk factor. 10,11 The high prevalence of pigmentary disorders in patients with high phtotype in Fitzpatrick scale would be one of the factors for a greater number of described cases in this population. However, there are reports in patients who are Asian and Caucasian descendants.…”
Section: Discussionmentioning
confidence: 99%
“…These findings were similar to the ones found by Berman et al 13 Many therapeutic options are described for the treatment of EO such as retinoic acid, glycolic acid, azelaic acid, Q-switched (755nm) laser, but all them with unsatisfactory results. 10,14 As most EO cases are iatrogenic resulting from inadequate use of hydroquinone for the treatment of melasma, dermatologists should pay attention not only to prevention but also to early diagnosis of EO. As there are few reports about the use of dermoscopy to help to diagnose EO the authors present three cases where dermoscopy was efficient in the differentiation between pre-existing melasma and exogenous ochronosis.…”
Section: Discussionmentioning
confidence: 99%
“…Experiments results showed that the inhibition of the enzyme that oxidized by hydroquinone, leading to the accumulation of homogentisic acid which transforms into ochronotic pigment. [10] In Riba's paper in 2010, there were 4 specific clinical reports which shows how hydroquinone affects skins. In case 01, a 36-year-old female patient who was treated with 2% concentration of hydroquinone for 5 years got facial melanoma appeared in molar region, and symmetrically on dorsal of the supralabial and nose (for 8 years??).…”
Section: Hydroquinone Ad Skin Diseasesmentioning
confidence: 99%
“…Reported cases of skin damage caused by using hydroquinone containing cosmetics Experiments were conducted to further discover the relationship between hydroquinone and exogenous ochronosis. Experiments results showed that the inhibition of the enzyme that oxidized by hydroquinone, leading to the accumulation of homogentisic acid which transforms into ochronotic pigment [10]. In Riba's paper in 2010, there were 4 specific clinical reports which shows how hydroquinone affects skins.…”
mentioning
confidence: 99%
“…Moin et al [ 3 ] found a statistically significant relationship between melasma and ethnicity, and phototype and grade of parity. Exogenous ochronosis has also been reported to be being misdiagnosed as a melisma treatment failure [ 76 ]. However, these prognostic factors lack sufficient scientific evidence.…”
Section: Bad Prognosis Indicatorsmentioning
confidence: 99%